Overview

Intradiscal Platelet Rich Plasma

Status:
Recruiting

Trial end date:
2024-07-30

Target enrollment:

Participant gender:

Summary

To assess changes in pain and function in patients with discogenic low back pain after a standard of care intradiscal injection of Platelet-Rich Plasma (PRP).

Phase:

Phase 4

Details

Lead Sponsor:

University of Utah